Defunct Company
Total Trials
6
As Lead Sponsor
4
As Collaborator
2
Total Enrollment
244
NCT00814645
Dose-Finding, Safety, Pharmacodynamic Effect Study of Sodium Nitrite Inhalation Solution in Normal, Healthy Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Dec 31, 2008
Completion: Jun 30, 2009
NCT01409122
Safety, Tolerability, and PK Parameters of Sodium Nitrite Inhalation Solution in Healthy Subjects
Start: Jul 31, 2011
Completion: Jan 31, 2012
NCT01725256
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
Phase: Phase 2
Start: Nov 30, 2012
Completion: Feb 28, 2014
NCT01725269
Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05
Start: Mar 31, 2013
Completion: Apr 30, 2014
NCT02262078
Inhaled Sodium Nitrite on Heart Failure With Preserved Ejection Fraction
Role: Collaborator
Start: Oct 31, 2014
Completion: Dec 31, 2015
NCT02742129
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Start: Aug 10, 2016
Completion: Dec 27, 2017